Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Saven

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Expert Review of Hematology|August 6, 2019
Novel therapeutics in hairy cell leukemiaAditya Sarvaria, Alan Saven
Leukemia Research|December 5, 2003
Cladribine activity in systemic mast cell disease: application of biochemistry in the modern era of molecular biologyJorge Nieva, Alan Saven
Expert Review of Anticancer Therapy|October 16, 2004
Cladribine: from the bench to the bedside--focus on hairy cell leukemiaNatalya Greyz, Alan Saven
Hematology/Oncology Clinics of North America|September 23, 2006
Cladribine in hairy cell leukemiaRajesh Belani, Alan Saven
Leukemia & Lymphoma|April 25, 2007
Understanding hairy cell leukemia geneticsJorge Nieva, Alan Saven
Blood Advances|June 17, 2026
Low-Dose Vemurafenib Plus Rituximab in Front-Line and Relapsed or Refractory Hairy Cell Leukemia: The Scripps RegimenDavid J Hermel, Alan Saven
Mayo Clinic Proceedings|January 4, 2012
My treatment approach to hairy cell leukemiaRahul R Naik, Alan Saven
Expert Review of Hematology|August 23, 2014
Hairy cell leukemia: a 'hair-raising' updateZheng Z Topp, Alan Saven
Cancer Treatment and Research|February 21, 2008
Hairy cell leukemiaPaul Timothy Fanta, Alan Saven
Expert Review of Anticancer Therapy|April 12, 2008
Cladribine in indolent non-Hodgkin's lymphomaDarren S Sigal, Alan Saven
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Expert Review of Hematology|August 6, 2019
Novel therapeutics in hairy cell leukemiaAditya Sarvaria, Alan Saven
Leukemia Research|December 5, 2003
Cladribine activity in systemic mast cell disease: application of biochemistry in the modern era of molecular biologyJorge Nieva, Alan Saven
Expert Review of Anticancer Therapy|October 16, 2004
Cladribine: from the bench to the bedside--focus on hairy cell leukemiaNatalya Greyz, Alan Saven
Hematology/Oncology Clinics of North America|September 23, 2006
Cladribine in hairy cell leukemiaRajesh Belani, Alan Saven
Leukemia & Lymphoma|April 25, 2007
Understanding hairy cell leukemia geneticsJorge Nieva, Alan Saven
Blood Advances|June 17, 2026
Low-Dose Vemurafenib Plus Rituximab in Front-Line and Relapsed or Refractory Hairy Cell Leukemia: The Scripps RegimenDavid J Hermel, Alan Saven
Mayo Clinic Proceedings|January 4, 2012
My treatment approach to hairy cell leukemiaRahul R Naik, Alan Saven
Expert Review of Hematology|August 23, 2014
Hairy cell leukemia: a 'hair-raising' updateZheng Z Topp, Alan Saven
Cancer Treatment and Research|February 21, 2008
Hairy cell leukemiaPaul Timothy Fanta, Alan Saven
Expert Review of Anticancer Therapy|April 12, 2008
Cladribine in indolent non-Hodgkin's lymphomaDarren S Sigal, Alan Saven
Pageof 7